Remgro reported adjusted earnings up 91% to 16c for H1 FY26 at Mediclinic Holdings level. Revenue rose 10% to $2.6bn. Volume growth and efficiency gains drove the surge. Leverage held at 3.1x.
Click here to read the SENS
Remgro reported adjusted earnings up 91% to 16c for H1 FY26 at Mediclinic Holdings level. Revenue rose 10% to $2.6bn. Volume growth and efficiency gains drove the surge. Leverage held at 3.1x.
Click here to read the SENS